Publication | Open Access
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
26
Citations
11
References
2019
Year
Phase 1/2Translational MedicinePharmacologyHematologySecondary MyelofibrosisMedicineMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1